AnwarAMalikNSiddiquiA, et al.Examining clinical pharmacist interventions and identifying opioid medication-related issues in patients with cancer. J Oncol Pharm Pract2025; 31: 1233–1240.
2.
World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization, 2018.
3.
CaraceniAShkodraM. Cancer pain assessment and classification. Cancers (Basel)2019; 11: 10.
4.
CrewsKRMonteAAHuddartR, et al.Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther2021; 110: 888–896.
5.
PergolizziJVTaylorRRaffaRB. Extended-release formulations of tramadol in the treatment of chronic pain. Expert Opin Pharmacother2011; 12: 1757–1768.
6.
ShresthaSKhatiwadaAPSapkotaB, et al.What is “opioid stewardship"? an overview of current definitions and proposal for a universally acceptable definition. J Pain Res2023; 16: 383–394.
7.
ShresthaSSapkotaSTeohSL, et al.Comprehensive assessment of pain characteristics, quality of life, and pain management in cancer patients: a multi-center cross-sectional study. Qual Life Res2024; 33: 2755–2771.
